Arrowhead Clinic Chiropractor Marietta is highlighting the critical importance of seeking immediate medical attention for ...

For benign paroxysmal positional vertigo (BPPV), the overall positive rate for positional tests is significantly higher in the morning than in the evening, according to a study published online Oct. 6 ...

Vestibular migraine is a type of migraine disorder marked by balance problems. It affects up to 3 percent of the population, ...

How one woman went from a severe alopecia areata diagnosis to finding the right prescription treatment for her—and getting ...

Hope Medicine (HopeMed), a clinical-stage innovative biotech company, in collaboration with a joint research team from Peking ...

The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive ...

The FDA approved Lynkuet, a new nonhormonal menopause drug that reduces moderate to severe hot flashes and night sweats.

A Derbyshire dad’s incurable brain cancer diagnosis, and his death less than two years later, has inspired his family to ...

The decision to discontinue production was driven by business considerations rather than concerns about the product’s safety or effectiveness.

The Food and Drug Administration (FDA) has approved Caplyta ® (lumateperone) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder (MDD) in adults.

A new treatment for those suffering from "chronic" eczema is set to be available on the NHS within the next three months.

The cream can be used at home and is applied twice a day to the affected areas on the hands and wrists - it should be offered ...